So far, the researchers have concluded that lineage of the T-cell receptor gene does not predict the behavior of the disease.
[6][7] Overall survival depends on the stage of the cancer when treatment is initiated, and on a composite of numerous risk factors.
Patients diagnosed early and/or with fewer risk factors can sometimes enter complete remission and expect much longer survival.
[2] Flow cytometry is a diagnostic tool in order to count/visualize the amount of lymphatic cells in the body.
Several molecular tumor profiling protocols have been initiated in Europe (e.g., MOSCATO-01, iTHER, and ESMART) to identify actionable lesions for targeted treatment in specific subgroups of patients.
[8] Natural killer (NK) cell therapy is used in pediatrics for children with relapsed lymphoid leukemia.
[10] One problem when using NK cells in order to fight off lymphoid leukemia is the fact that it is hard to amount enough of them to be effective.
[10] One can receive donations of NK cells from parents or relatives through bone marrow transplants.